Journal
CELL BIOLOGY AND TOXICOLOGY
Volume 31, Issue 2, Pages 83-94Publisher
SPRINGER
DOI: 10.1007/s10565-015-9295-8
Keywords
Autophagy; Catabolism; Proteasome; TNF-alpha; Ubiquitin
Categories
Funding
- Stellenbosch University
Ask authors/readers for more resources
Circulating TNF-alpha levels are elevated in a wide variety of cardiovascular pathologies including congestive heart failure (CHF). This cytokine is one of the leading mediators of the immune inflammatory response with widespread biological functions regulated by membrane receptors. The pathophysiological implication of the downstream effects of activating the TNF-alpha system in CHF appears to depend on its direct effects on the heart and endothelium. Evidence supporting the notion that circulating TNF-alpha promotes protein breakdown was initially obtained from studies utilizing transgenic animals overexpressing TNF-alpha, animals with experimental diseases that augment TNF-alpha and in animals treated with exogenous TNF-alpha. It was then demonstrated that TNF-alpha acts directly on cultured myotubes to stimulate catabolism; however, whether the effects are the same in the heart remains poorly understood. The present study shows that TNF-alpha treatment induces autophagy, but clearance through this pathway appears obstructed and, consequently, results in increased protein ubiquitination. Furthermore, prolonged TNF-alpha treatment enhanced E3 ubiquitin ligase expression but reduced activity of the proteasome. These results suggest that TNF-alpha induces sarcomeric dysfunction and remodeling by disrupting autophagy and elevating the degradation of myofibrillar proteins. Therefore, myocardial remodeling, as a consequence to reduced contractile proteins, contributes to contractile dysfunction, a symptom often observed in the end stages of CHF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available